Utility of PCD Diagnostics to Improve Clinical Care
Condition:   Primary Ciliary Dyskinesia Intervention:   Device: Nasal Nitric Oxide testing Sponsors:   Connecticut Children's Medical Center;   UConn Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder;   Major Depressive Disorder;   Tardive Dyskinesia Intervention:   Drug: Valbenazine Sponsor:   Neurocrine Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2023 Category: Research Source Type: clinical trials